BPC-157 Promotes New Blood Vessel and Tissue Growth Better Than Standard Ulcer Drugs
BPC-157 stimulated new blood vessel formation and granulation tissue growth more effectively than H2-blockers, omeprazole, or sucralfate, explaining its superior wound healing properties.
Quick Facts
What This Study Found
BPC-157 promoted significantly more angiogenesis and granulation tissue formation than H2-blockers, omeprazole, or sucralfate, identifying its primary healing mechanism as enhanced new tissue growth rather than acid suppression.
Key Numbers
How They Did This
Animal study comparing BPC-157 (IP and IG routes) to ranitidine, omeprazole, and sucralfate for angiogenesis and granulation tissue formation in various ulcer models.
Why This Research Matters
Understanding that BPC-157 heals by growing new blood vessels and tissue — not just reducing acid — explains why it works across different organ systems, not just the stomach.
The Bigger Picture
Most ulcer drugs work by reducing stomach acid. BPC-157's mechanism — growing new blood vessels and tissue — is fundamentally different and explains its broad healing ability across gut, skin, bone, and muscle.
What This Study Doesn't Tell Us
Animal models of ulcer healing. The specific molecular pathways for BPC-157's angiogenic effect were not fully characterized.
Questions This Raises
- ?Which angiogenic pathways does BPC-157 activate?
- ?Could BPC-157 be combined with acid-reducing drugs for synergistic ulcer healing?
- ?Does BPC-157's angiogenic effect explain its bone and muscle healing too?
Trust & Context
- Key Stat:
- Outperformed all BPC-157 promoted more angiogenesis and granulation tissue than standard ulcer drugs H2-blockers, omeprazole, and sucralfate
- Evidence Grade:
- Preliminary animal evidence with direct comparative data against established medications, providing clear mechanistic insight.
- Study Age:
- Published in 1999. BPC-157's angiogenic mechanism has been confirmed in subsequent studies and is now considered central to its multi-organ healing effects.
- Original Title:
- The effect of pentadecapeptide BPC 157, H2-blockers, omeprazole and sucralfate on new vessels and new granulation tissue formation.
- Published In:
- Journal of physiology, Paris, 93(6), 479-85 (1999)
- Authors:
- Sikiric, P(36), Separovic, J(12), Anic, T(17), Buljat, G, Mikus, D, Seiwerth, S, Grabarevic, Z, Stancic-Rokotov, D, Pigac, B, Hanzevacki, M, Marovic, A, Rucman, R, Petek, M, Zoricic, I, Ziger, T, Aralica, G, Konjevoda, P, Prkacin, I, Gjurasin, M, Miklic, P, Artukovic, B, Tisljar, M, Bratulic, M, Mise, S, Rotkvic, I
- Database ID:
- RPEP-00560
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
How does BPC-157 heal differently from antacids?
Antacids and drugs like omeprazole reduce stomach acid. BPC-157 heals by growing new blood vessels and tissue directly — a fundamentally different approach that works even in tissues that have nothing to do with stomach acid.
Is angiogenesis safe?
The body naturally uses angiogenesis for healing. BPC-157 appears to promote appropriate wound-healing angiogenesis rather than pathological blood vessel growth, though this distinction needs more research.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00560APA
Sikiric, P; Separovic, J; Anic, T; Buljat, G; Mikus, D; Seiwerth, S; Grabarevic, Z; Stancic-Rokotov, D; Pigac, B; Hanzevacki, M; Marovic, A; Rucman, R; Petek, M; Zoricic, I; Ziger, T; Aralica, G; Konjevoda, P; Prkacin, I; Gjurasin, M; Miklic, P; Artukovic, B; Tisljar, M; Bratulic, M; Mise, S; Rotkvic, I. (1999). The effect of pentadecapeptide BPC 157, H2-blockers, omeprazole and sucralfate on new vessels and new granulation tissue formation.. Journal of physiology, Paris, 93(6), 479-85.
MLA
Sikiric, P, et al. "The effect of pentadecapeptide BPC 157, H2-blockers, omeprazole and sucralfate on new vessels and new granulation tissue formation.." Journal of physiology, 1999.
RethinkPeptides
RethinkPeptides Research Database. "The effect of pentadecapeptide BPC 157, H2-blockers, omepraz..." RPEP-00560. Retrieved from https://rethinkpeptides.com/research/sikiric-1999-the-effect-of-pentadecapeptide
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.